Why the study?
What is the most cost-effective strategy to screen for left ventricular systolic dysfunction?
What is the most cost-effective strategy to screen for left ventricular systolic dysfunction?
Community-based screening for left ventricular systolic dysfunction using various modalities is cost-effective, particularly in high-risk populations.
Thus several different modalities allow cost-effective community-based screening for LVSD, especially in high-risk subjects. Such programmes would be cost-effective and miss few cases of LVSD in the community.
No takes yet. Share an insight, caveat, or question.
Galasko et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: